The CXCL12/CXCR4/ACKR3 Response Axis in Chronic Neurodegenerative Disorders of the Central Nervous System: Therapeutic Target and Biomarker

被引：7

作者：

Yan, Yudie ^{[1
]}

Su, Jingtong ^{[2
]}

Zhang, Zhen ^{[1
]}

机构：

[1] China Med Univ, Affiliated Hosp 1, Dept Ultrasound, Shenyang 110001, Liaoning, Peoples R China

[2] Jinzhou Med Univ, Jinzhou City, Liaoning, Peoples R China

来源：

CELLULAR AND MOLECULAR NEUROBIOLOGY | 2022年 / 42卷 / 07期

基金：

中国国家自然科学基金;

关键词：

ACKR3; CXCL12; CXCR4; Neurodegenerative disorders; Central nervous system; ALZHEIMERS-DISEASE; CXCL12; EXPRESSION; CHEMOKINE CXCL12; MICROGLIA; MIGRATION; RECEPTOR; CELLS; MODEL; GLYCOSAMINOGLYCANS; DEFICIENT;

D O I：

10.1007/s10571-021-01115-1

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

There has been an increase in the incidence of chronic neurodegenerative disorders of the central nervous system, including Alzheimer's and Parkinson's diseases, over the recent years mostly due to the rise in the number of elderly individuals. In addition, various neurodegenerative disorders are related to imbalances in the CXCL12/CXCR4/ACKR3 response axis. Notably, the CXC Chemokine Ligand 12 (CXCL12) is essential for the development of the central nervous system. Moreover, the expression and distribution of CXCL12 and its receptors are associated with the aggravation or alleviation of symptoms of neurodegenerative disorders. Therefore, the current review sought to highlight the specific functions of CXCL12 and its receptors in various neurodegenerative disorders, in order to provide new insights for future research.

引用

下载

页码：2147 / 2156

页数：10

共 50 条

[21] CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target
Mizuhiko Terasaki
Yasuo Sugita
Fumiko Arakawa
Yosuke Okada
Koichi Ohshima
Minoru Shigemori
Brain Tumor Pathology, 2011, 28 : 89 - 97
[22] Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system
Williams, Jessica L.
Patel, Jigisha R.
Daniels, Brian P.
Klein, Robyn S.
JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 211 (05): : 791 - 799
[23] The contributory roles of the CXCL12/CXCR4/CXCR7 axis in normal and malignant hematopoiesis: A possible therapeutic target in hematologic malignancies
Mehrpouri, Mahdieh
EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 920
[24] CXCR4/CXCL12 axis: "old" pathway as "novel" target for anti-inflammatory drug discovery
Lu, Liuxin
Li, Junjie
Jiang, Xiaoying
Bai, Renren
MEDICINAL RESEARCH REVIEWS, 2024, 44 (03) : 1189 - 1220
[25] Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell
Wang, Zhidong
Sun, Jian
Feng, Yeqian
Tian, Xiaocai
Wang, Bin
Zhou, Yong
TUMOR BIOLOGY, 2016, 37 (07) : 8515 - 8528
[26] Unravelling the CXCL12/CXCR4 Axis in breast cancer: Insights into metastasis, microenvironment interactions, and therapeutic opportunities
Garg, Priyanka
Jallepalli, Venkateswara Rao
Verma, Sonali
HUMAN GENE, 2024, 40
[27] CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy
S Singh
S K Srivastava
A Bhardwaj
L B Owen
A P Singh
British Journal of Cancer, 2010, 103 : 1671 - 1679
[28] CXCR4/CXCL12 Axis in Non Small Cell Lung Cancer (NSCLC) Pathologic Roles and Therapeutic Potential
Wald, Ori
Shapira, Oz M.
Izhar, Uzi
THERANOSTICS, 2013, 3 (01): : 26 - 33
[29] ACKR3 promotes CXCL12/CXCR4-mediated cell-to-cell-induced lymphoma migration through LTB4 production
Antonello, Paola
Pizzagalli, Diego U.
Foglierini, Mathilde
Melgrati, Serena
Radice, Egle
Thelen, Sylvia
Thelen, Marcus
FRONTIERS IN IMMUNOLOGY, 2023, 13
[30] CXCL12/CXCR4 pathway as a novel therapeutic target for RNF213-associated pulmonary arterial hypertension
Takahiro Hiraide
Noboru Tsuda
Mizuki Momoi
Yoshiki Shinya
Motoaki Sano
Keiichi Fukuda
Junji Shibahara
Junko Kuramoto
Yae Kanai
Kenjiro Kosaki
Yoji Hakamata
Masaharu Kataoka
Scientific Reports, 14 (1)

← 1 2 3 4 5 →